- Home
- NSPR vs HNNA Comparison
NSPR vs HNNA Comparison
Compare NSPR & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- HNNA
- Stock Information
- Founded
- NSPR 2005
- HNNA 1989
- Country
- NSPR Israel
- HNNA United States
- Employees
- NSPR N/A
- HNNA N/A
- Industry
- NSPR Medical/Dental Instruments
- HNNA Investment Managers
- Sector
- NSPR Health Care
- HNNA Finance
- Exchange
- NSPR Nasdaq
- HNNA Nasdaq
- Market Cap
- NSPR 63.0M
- HNNA 73.8M
- IPO Year
- NSPR N/A
- HNNA N/A
- Fundamental
- Price
- NSPR $2.93
- HNNA $12.01
- Analyst Decision
- NSPR Strong Buy
- HNNA
- Analyst Count
- NSPR 2
- HNNA 0
- Target Price
- NSPR $4.75
- HNNA N/A
- AVG Volume (30 Days)
- NSPR 78.6K
- HNNA 18.0K
- Earning Date
- NSPR 11-12-2024
- HNNA 02-06-2025
- Dividend Yield
- NSPR N/A
- HNNA 4.55%
- EPS Growth
- NSPR N/A
- HNNA 46.17
- EPS
- NSPR N/A
- HNNA 0.92
- Revenue
- NSPR $6,821,000.00
- HNNA $29,646,000.00
- Revenue This Year
- NSPR $13.31
- HNNA N/A
- Revenue Next Year
- NSPR $52.91
- HNNA N/A
- P/E Ratio
- NSPR N/A
- HNNA $14.07
- Revenue Growth
- NSPR 24.70
- HNNA 23.42
- 52 Week Low
- NSPR $1.81
- HNNA $6.38
- 52 Week High
- NSPR $3.42
- HNNA $13.88
- Technical
- Relative Strength Index (RSI)
- NSPR 52.69
- HNNA 54.85
- Support Level
- NSPR $2.78
- HNNA $11.80
- Resistance Level
- NSPR $3.15
- HNNA $13.88
- Average True Range (ATR)
- NSPR 0.22
- HNNA 0.84
- MACD
- NSPR -0.03
- HNNA -0.00
- Stochastic Oscillator
- NSPR 47.58
- HNNA 50.83
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced and fixed income products. It provides investment advisory services and shareholder services to the Hennessy Funds. Its investment advisory services include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities in accordance with the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.